Secondary Acute Myeloid Leukemia is a clonal disorder caused by malignant transformation of a bone marrow-derived, self-renewing stem cell or progenitor, in which the disease arises from apre-existing myelodysplastic. This leads to a decreased rate of self-destruction and aberrant differentiation causing an accumulation in the organs and bone marrow by these myeloid cells. In order for Myeloid Leukemia to be considered acute the bone marrow must be greater than 20% leukemic blasts.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Secondary Acute Myeloid Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 863 products for the study of Secondary Acute Myeloid Leukemia that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.